Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Corticosteroids for viral central nervous system infections47
Complexities of cardiomyopathy in septic shock41
Strongyloidiasis-related lung involvement: too much of a bad thing39
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel36
Editorial introductions35
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV34
Surgical management of cystic echinococcosis of the liver33
La Crosse virus encephalitis in children31
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era29
Skin and soft tissue infections in the elderly28
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians28
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes27
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside27
From diagnosis to management: current perspectives on congenital cytomegalovirus infection25
Mycobacterial skin infection25
Viral meningitis and encephalitis: an update25
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?24
New therapies for nontuberculous mycobacterial lung infection24
Progress and challenges in human papillomavirus and cervical cancer in southern Africa23
Fusarium species central nervous system infection23
Typhoid fever control in the 21st century: where are we now?22
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response22
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management21
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients21
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies20
Mpox in people living with HIV20
Tuberculosis molecular bacterial load assay in the management of tuberculosis20
Tick-borne encephalitis20
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention19
Resistant herpes simplex virus infections – who, when, and what's new?19
Malaria in pregnancy: baby steps19
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach17
Does climate change threaten delivery of HIV care in resource-limited settings?17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis17
Diagnostic stewardship: what impacts antibiotics use?16
Editorial introductions16
Using antibiotics wisely16
Diagnostic approach and update on encephalitis16
CMV antiviral stewardship in transplantation – the next frontier16
Gut microbiome and its clinical implications: exploring the key players in human health16
The plumbing problem: rising antimicrobial resistance in building water systems15
Immunotherapeutic approaches to HIV cure and remission15
Appropriate surgical management in skin and soft tissue infections15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV14
The impact of coronavirus disease 2019 on people with HIV14
Update on the treatment of chronic pulmonary aspergillosis14
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy14
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1914
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections13
The microbiota in respiratory tract infections: from association to intervention13
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles13
Risk stratification for selecting empiric antibiotherapy during and after COVID-1912
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients12
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities12
Editorial: Pathogenesis and immune response – editorial12
Childhood tuberculosis12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
Editorial introductions12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
An overview of risk factors, management and prevention of cochlear implant infections12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
Respiratory metagenomics: route to routine service11
Short treatment duration for community-acquired pneumonia11
Update on drug treatments for multidrug resistant tuberculosis11
Data science for pediatric infectious disease: utilizing COVID-19 as a model11
Burden of influenza in the elderly: a narrative review10
Urinary tract infections in immunocompromised patients10
The microbiome as a biomarker of anal precancerous lesions in people with HIV10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities10
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis10
Travellers’ diarrhoea – solidifying our knowledgebase10
Short-course antibiotic strategies for ventilator-associated pneumonia10
The disease burden of respiratory syncytial virus in Infants10
Identifying patients with difficult-to-treat acute bacterial skin infections9
A new era of HIV care for age-associated multimorbidity9
Chagas disease in the immunocompromised host9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Novel techniques in the treatment of skin and soft tissue infection9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Therapeutic agents for the treatment of human mpox9
The role of Gram-negative bacteria in skin and soft tissue infections9
Skin and soft tissue infections in solid organ transplants9
Immune responses and severe dengue: what have we learned?9
Antibiotic treatment of acute bacterial skin and skin structure infections9
The evolution of knowledge for treating Gram-negative bacterial infections9
Neurobrucellosis9
0.085645198822021